STAT

AUGUST 17, 2024

It’s been a hard week for the psychedelics pioneer Rick Doblin.  First, the Food and Drug Administration declined to approve the MDMA-assisted therapy for post-traumatic stress disorder developed by Lykos Therapeutics, a company that he founded. The next day, the journal Psychopharmacology retracted three studies on the treatment, in which many authors were associated with Lykos or the nonprofit Doblin founded, the Multidisciplinary Association for Psychedelic Studies (MAPS).

361

361

The Guardian - Pharmaceutical Industry

AUGUST 17, 2024

Health leaders warn that global response to virus is test case for equity and preparation for future pandemics A failure to show solidarity with African countries at the heart of the mpox outbreak will put the world at risk and harm preparations for future pandemics, health leaders have said. The World Health Organization on Wednesday declared an international public health emergency in the face of rising cases that are spreading beyond the Democratic Republic of the Congo (DRC), where the virus

111

111

STAT

AUGUST 17, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

261

261

Pharmacy Times

AUGUST 17, 2024

New payment frameworks are emerging, but pharmacists need to be central to the ongoing food as medicine movement.

58

58

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Drug Patent Watch

AUGUST 17, 2024

This chart shows the pharmaceutical companies with the most patents in Netherlands. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Drug Patent Watch

AUGUST 17, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

52

52

Pharmacy Times

AUGUST 17, 2024

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

Community Pharmacies 32

Community Pharmacies 32

Drug Patent Watch

AUGUST 17, 2024

Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

52

52